EXHIBIT 21.1
Scorpius Holdings, Inc. Subsidiaries
Name of Subsidiary | Jurisdiction |
Heat Biologics I, Inc | Delaware |
Heat Biologics III, Inc. | Delaware |
Heat Biologics IV, Inc. | Delaware |
Heat Biologics GmbH | Germany |
Heat Biologics Australia Pty LTD | Australia |
Zolovax, Inc. | Delaware |
Pelican Therapeutics, Inc.1 | Delaware |
Skunkworx Labs, Inc.3 | Delaware |
Delaware | |
Abacus Biotech, Inc.3 | Delaware |
Blackhawk Bio, Inc.3 | Delaware |
| |
1Formerly Heat Biologics II, Inc. believed to be formed in 2008 and divested in 2012. Refer to 2020 10-K.
Jeffrey Wolf was issued an option to purchase up to 5% of the outstanding shares of Scorpius Biomanufacturing, Inc. and William Ostrander was issued an option to purchase up to 1% of the outstanding shares of Scorpius Biomanufacturing, Inc., both options were exercised in full.
3Each of these entities are parties to a subsidiary incentive plan pursuant to which options have been issued.